Stocks and InvestingStocks and Investing
Fri, September 9, 2022
Thu, September 8, 2022
Wed, September 7, 2022
Tue, September 6, 2022

Raghuram Selvaraju Maintained (AQST) at Strong Buy with Decreased Target to $5 on, Sep 6th, 2022


Published on 2024-10-27 22:54:28 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Maintained "Aquestive Therapeutics, Inc." (AQST) at Strong Buy with Decreased Target from $6 to $5 on, Sep 6th, 2022.

Raghuram has made no other calls on AQST in the last 4 months.



There is 1 other peer that has a rating on AQST. Out of the 1 peers that are also analyzing AQST, 0 agree with Raghuram's Rating of Hold.



This is the rating of the analyst that currently disagrees with Raghuram


  • James Molloy of "Alliance Global Partners" Initiated at Strong Buy and Held Target at $10 on, Tuesday, August 30th, 2022